chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: MMR
Symptoms: Measles post vaccine
Clinical narrative: Information has been received from a physician concerning a "very old" female who was vaccinated with MMR II. The patient recently received MMR II and came down with measles and was hospitalized. Unspecified medical attention was sought. Additional information has been requested.
Age: 14.0
Sex: M
Vaccine: HEP, HEPA, MMR, MNQ, VARCEL
Symptoms: Abdominal pain, Anorexia, Blood glucose increased, Headache, Nausea
Clinical narrative: Information has been received from a physician concerning a 14-year-old male with type 1 diabetes mellitus, no known drug allergies, and a family history of migraines (paternal grandmother) who on 05-AUG-2008 was vaccinated into the right arm with the second dose of MMR II (Lot number 659703/0666X), and into the left arm with the second dose of VARIVAX (Merck) (Lot number 660822/0338X). Concomitant therapy included HAVRIX (unspecified, lot number ahavb118ab, first dose, right arm), RECOMBIVAX HB (unspecified, lot number 1714U, second dose, right arm), MENACTRA (lot number U2605aa, first dose, left arm) and insulin. It was reported that at the time of the vaccinations, the patient had no known illnesses. On-06-AUG-2008, (the morning after the vaccines were administered), the patient presented to the emergency room with a severe debilitating headache and vomiting. It was reported that the patient also had abdominal pain, pain, nausea, anorexia and neck pain. On that same date, his blood sugar was 183. It was reported that the patient was treated with TORADOL 30 mg diluted with normal saline slow IVP. The patient improved, and he was discharged from the emergency room on 06-AUG-2008. The patient recovered on 07-AUG-2008. This is an amended report. The serious criteria of disabling for severe debilitating headache has been changed to yes. This is a corrected report as amended.
Age: 14.0
Sex: M
Vaccine: HEP, HEPA, MMR, MNQ, VARCEL
Symptoms: Neck pain, Pain, Vomiting
Clinical narrative: Information has been received from a physician concerning a 14-year-old male with type 1 diabetes mellitus, no known drug allergies, and a family history of migraines (paternal grandmother) who on 05-AUG-2008 was vaccinated into the right arm with the second dose of MMR II (Lot number 659703/0666X), and into the left arm with the second dose of VARIVAX (Merck) (Lot number 660822/0338X). Concomitant therapy included HAVRIX (unspecified, lot number ahavb118ab, first dose, right arm), RECOMBIVAX HB (unspecified, lot number 1714U, second dose, right arm), MENACTRA (lot number U2605aa, first dose, left arm) and insulin. It was reported that at the time of the vaccinations, the patient had no known illnesses. On-06-AUG-2008, (the morning after the vaccines were administered), the patient presented to the emergency room with a severe debilitating headache and vomiting. It was reported that the patient also had abdominal pain, pain, nausea, anorexia and neck pain. On that same date, his blood sugar was 183. It was reported that the patient was treated with TORADOL 30 mg diluted with normal saline slow IVP. The patient improved, and he was discharged from the emergency room on 06-AUG-2008. The patient recovered on 07-AUG-2008. This is an amended report. The serious criteria of disabling for severe debilitating headache has been changed to yes. This is a corrected report as amended.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Diabetes mellitus, Dysuria, Glucose urine present
Clinical narrative: Information has been received from a physician concerning a 4 year old male with egg allergy and a history of asthma who on 08-AUG-2008 was vaccinated with a second dose of MMR II, IM, (Lot # 660020/0504X), manufactured with rHA. The first dose was given on 10-DEC-2004. On 15-AUG-2008, the patient was seen in the office to evaluate recently developed dysuria. A urine test for diabetes was performed. The patient was then diagnosed with diabetes. The patient was hospitalized overnight and was then released. No product quality complaint was involved. Additional information has been requested.
Age: 32.0
Sex: F
Vaccine: MMR
Symptoms: Mumps
Clinical narrative: Information has been received from a consumer concerning her 32 year old daughter who recently received a booster dose for MMR II. It was reported that she developed mumps and ended up being admitted to the hospital. No product quality complaint involved. This is one of several reports from the same source. Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Idiopathic thrombocytopenic purpura
Clinical narrative: Information has been received from a physician concerning a 5 year old female who received her first dose of MMR II at 15 months of age (approximately 2005) and developed idiopathic thrombocytopenic purpura. The patient sought medical attention. The patient recovered after treatment. Upon internal review, idiopathic thrombocytopenic purpura was determined to be an other important medical event. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Encephalitis
Clinical narrative: Information has been received from a physician concerning his wife, who as a child was vaccinated with MMR II. Subsequently the patient experienced encephalitis and was hospitalized. On an unspecified date, the patient recovered from encephalitis. Encephalitis was considered to be disabling and immediately life-threatening. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Apraxia, Expressive language disorder, Gastrointestinal disorder, Rash, Staring
Clinical narrative: Information has been received from a consumer concerning her now 6 year old son with "family genetic history (predisposition) of motor skill problems" who in August 2003, was vaccinated with MMR II (HSA) (total daily dose, route and site not reported). Together the patient was vaccinated with VARIVAX (total daily dose, route and site not reported). "Within a day or 2" of receiving the vaccines, the patient began to stare into space for 2 days and his limited language skills (mom-mom and pop-pop) stopped. Also his face began to swell and he developed a rash. He was diagnosed with apraxia shortly after receiving the vaccines. He was undergoing therapy 5 days a week for the past 4 years and had "physical issues with his gut/gastrointestinal problems". The patient was not recovered from above events. The patient sought medical attention. No further information is available.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Swelling face
Clinical narrative: Information has been received from a consumer concerning her now 6 year old son with "family genetic history (predisposition) of motor skill problems" who in August 2003, was vaccinated with MMR II (HSA) (total daily dose, route and site not reported). Together the patient was vaccinated with VARIVAX (total daily dose, route and site not reported). "Within a day or 2" of receiving the vaccines, the patient began to stare into space for 2 days and his limited language skills (mom-mom and pop-pop) stopped. Also his face began to swell and he developed a rash. He was diagnosed with apraxia shortly after receiving the vaccines. He was undergoing therapy 5 days a week for the past 4 years and had "physical issues with his gut/gastrointestinal problems". The patient was not recovered from above events. The patient sought medical attention. No further information is available.
Sex: M
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a medical assistant concerning an adult male who was vaccinated with a dose of MMR II as a child. The patient had titers drawn and showed no immunity to mumps. The patient sought medical attention with an office visit. Additional information has been requested.
Sex: F
Vaccine: MMR
Symptoms: Accidental exposure, Laceration
Clinical narrative: Information has been received from a healthcare worker concerning a nurse regarding MMR II. The nurse was cut on shattered vials of vaccine received in a recent shipment. OMC is taking as a shipping issue. Additional information has been requested.
Age: 32.0
Sex: M
Vaccine: MMR
Symptoms: Myalgia, Pyrexia
Clinical narrative: Information has been received from a nurse practitioner concerning a 32 year old male who on 09-DEC2008 was vaccinated with MMR II SQ, 0.5ml. On 16-DEC-2008 the patient experienced fever and widespread myalgia. It is unknown if this was the first dose of MMR II. The patient did not have lab diagnostics studies. At time of the reporting the patient was not recovered. The patient sought medial attention by email to nurse practitioner. No further information is available.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Adverse reaction, Pyrexia, Rash
Clinical narrative: Information has been received from a consumer concerning her 12 month old son who was vaccinated with a dose of MMR II (lot# not provided) 0.5ml, and shortly after getting the vaccine he had a "violent reaction" to it. He had a "very high fever" and a rash. At the time of the report the patient had completely recovered. No further information is available.
Age: 65.0
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative, Rubella antibody positive, Varicella zoster virus serology positive
Clinical narrative: Information has been received from a physician concerning a female with DEMEROL allergy, arthritis, osteoporosis, hyperlipidaemia and hypothyroidism who was vaccinated with 1 dose of MM II (lot number not reported) on an unspecified date.  Concomitant therapy included LEVOTHYROXINE NA and LIPITOR.  Subsequently the patient had a negative mumps titer.  The patient was seen for medical attention.  Follow up information was received from a physician who reported the 67 year old patient was vaccinated with a dose of MM II on 03-APR-20006 (lot number not provided).  No physical adverse event other then a titer report negative on 12-NOV-2008.  Laboratory test results included:  VARICELLA -Z AB was positive, mumps IgG SCR was negative.  rubella AB (IgG) was positive, and rubella IgG AB was immune.  Additional information is not expected.
Age: 34.0
Sex: F
Vaccine: DT, MMR, VARCEL
Symptoms: Hepatitis viral test, Mumps antibody test negative, Varicella zoster serology negative
Clinical narrative: Initial information has been received from a pharmacist and follow-up information was received from a registered nurse concerning a 34-year-old female registered nurse who, on 12-MAR-2007 (previously reported as March 2007), was vaccinated with MMR II (manufacturer unspecified), and now has a negative mumps titer (date unspecified). Concomitant vaccines administered on 12-MAR-2007 included varicella virus vaccine live and DT (manufacturer unspecified). At the time of the report the patient's status was unknown. The patient had the following laboratory test: 25-Mar-2008: serum hepatitis C antibody test (pending). 25-Mar-2008: serum rubella immunoglobulin G antibody test (4.13). 25-Mar-2008: serum varicella zoster virus antibody test (2.05). 25-Mar-2008: serum mumps immunoglobulin G antibody test (<0.91). A product quality complaint was not reported. No further information is available.
Age: 8.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Measles
Clinical narrative: Information has been received from a consumer concerning her daughter with no pertinent medical history or drug allergies who on 01-MAR-2001 and 10-AUG-2005 was vaccinated with her first and second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot# 634420/0012L, 647106/0483R) (HSA). Concomitant vaccination administered on 01-MAR-2001 included the third dose of hepatitis B virus vaccine rHBsAg (MSD) (lot# 638081/1667X). Concomitant vaccinations administered on 10-AUG-2005 included the fifth dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and the fourth dose of inactivated poliovirus vaccine and the fourth dose of inactivated poliovirus vaccine (unspecified) (unspecified). On 29-MAR-2008 the patient experienced measles. The patient was taken to the emergency room but was not hospitalized. No labs or diagnostic studies were performed. Therapy with measles-mumps-rubella vaccine was discontinued. The patient was noted to be recovering. There was no product quality complaint. No further information is available.
Age: 6.0
Sex: F
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test positive, Rubella antibody positive
Clinical narrative: Information has been received from a registered nurse concerning a 22 year female health worker with no pertinent medical history who, on 16-Sep-1986, was vaccinated with MMR II . There was no concomitant medication. On 14-Nov-1991, the patient was vaccinated with her second dose of MMR II. On 28-Mar-2008, the patient had an MMR titer drawn with the following results: negative measles titer, just adequate mumps titer, and rubella titer adequate. No problems were reported. The product quality complaint was not involved. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Injection site erythema, Injection site rash, Pyrexia
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a patient who on approximately 20-MAR-2008 ("in the last 2 weeks") was vaccinated with a 0.5 ml dose of MMRII (lot number and site not reported.  It was reported on an unspecified date, that these three patients were experiencing a fever, rash and injection site erythema after receiving MMRII.  The patients were reported as recovered on an unspecified date.  There was no product quality complaint.  Follow up information was received on 11-APR-2008 from a nurse who reported that she did not know the names of these patients and there was no hospitalization.  This is one of several reports from the same source.  Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: MMR
Symptoms: Lymphadenitis, Mumps antibody test negative
Clinical narrative: Information has been received from a nurse practitioner (NP) concerning a 19 year old female, with no prior medical conditions, who was vaccinated at a hospital facility, by another provider, with a third dose of MMR II. It was noted the patient had not seroconverted for the mumpsvax component of the vaccine, and therefore a third dose was given. On 08 APR 2008 the patient was seen by the NP for lymphadenitis on her right side. Her temperature was 98 degrees. Given that treatment with a course of AUGMENTIN, 1000 mg BID was just started the day of reporting, 08 APR 2008, it was noted that there was no improvement as yet. It was noted that the patient had not gone to the emergency room. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Diarrhoea, Dyspnoea, Nausea, Urticaria, Vomiting
Clinical narrative: Information has been received from a PharmD. concerning a 5-year-old male with an allergy to porcine and bovine gelatin who in approximately 2006 " about 3 years ago" was vaccinated with a dose of MMR II. In approximately 2006 "about three years ago" the patient experienced hives, nausea, vomiting, diarrhea and difficulty breathing post vaccination. The patient sought medical attention via an office visit and was treated with BENADRYL and a steroid. On an unspecified date the patient recovered.  A product quality complaint was not involved. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: DTAPIPV, MMR
Symptoms: Chest pain, Laboratory test, Neurological examination, Skin discolouration
Clinical narrative: Information has been received from a pharmacist concerning a 19 year old female with a history of convulsions in childhood who on 19-NOV-2007 was vaccinated with a second dose of MMRII vaccine (Wistar RA 27/3) (Lot # 655415/0748U). Concomitant vaccine therapy that same day included DTAP-IPV vaccine.  The pharmacist reported that the patient developed chest pain and her hands turned black and blue after receiving her second vaccination with MMRII vaccine (Wistar RA 27/3) (date and or time of onsets not specified). The patient had received a first dose of MMRII vaccine (Wistar RA 27/3 on 4 JAN 1990. On 24-DEC-2007, the patient went to the emergency room (ER) and underwent several unspecified outpatient tests, and was subsequently released to home without a diagnosis. "Around the same time" the patient was seen by both a neurologist and cardiologist. The patient was also seen at a hospital for additional testing. On 08 APR 2008 the patient went to the ER again with chest pain and black hands. At the time of reporting there was no diagnosis and the patient had not yet recovered. There was no product quality complaint. Additional information has been requested.
Age: 47.0
Sex: F
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a 47 year old female pharmacist reporting on herself with an unknown medical history and unknown drug allergies/reactions who has received 4 doses of MMR II (lot number, dose and site not reported) subcutaneously. The patient's first dose was when she was younger, her second dose was given in college during 1980-1984 time period, her third dose given in 2003-2004 time period, and her fourth dose in 2006. The patient stated after four doses of MMR II, she still shows no immunity to rubella as indicated by 3 titer tests performed on an unspecified dates. She sought unspecified medical attention and has not recovered. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Livedo reticularis, Rash generalised, Upper respiratory tract infection
Clinical narrative: Information has been received from a physician concerning a 1-year-old male with a history of stroke and heart problems who on 10-APR-2008 was vaccinated with a dose of MMRII (lot number not provided).  Concomitant vaccinations administered on that same day included a dose of VARIVAX, a dose of PREVENAR and a dose of ACTHIB.  The physician reported that on 10-APR-2008, the patient became mottle and developed a rash from head to toe.  On 11-APR-2008, the patient was seen in the physician's office and his rash was noted to be cleaning up.  At that time, it was noted that the patient had also developed upper respiratory problems.  At the time of this report, the patient was noted to be recovering.  Additional information has been requested.
Age: 28.0
Sex: F
Vaccine: MMR
Symptoms: Antibody test negative, Laboratory test normal
Clinical narrative: Information has been received from a physician concerning an approximately 28-year-old female with no medical history or allergies who as a child was vaccinated SC with the first dose of MMR. There was no concomitant therapy. Titers were listed as equivocal. In approximately 2003, the patient was vaccinated SC with a booster dose of MMR. There was no concomitant therapy. In 2008 the patient's titers were also listed as equivocal. At the time of this report, the outcome was unknown. Additional information has been requested.
Age: 1.7
Sex: M
Vaccine: MMR
Symptoms: Abnormal behaviour, Anger, Crying, Hyperhidrosis, Movement disorder
Clinical narrative: Information has been received from a physician concerning a white male who, on an undisclosed date, was vaccinated with a second dose of MMR II, manufactured with HSA.  At the time of the report, 09-MAY-2008, there were no concomitant medications and there was no illness at the time of the second vaccination that was administered in 24-MAR-2008 in the AM.  It was noted that the mother reported that the patient developed (unspecified) sudden behavior problems.  It was noted that the physician was contacted, but it unknown if medical attention was sought.  There was no product quality complaint.  No laboratory/diagnostic studies were performed.  At the time of reporting the patient had not yet recovered.  Follow up information was received from a physician who reported that the behavioral changes were outbursts of rage that began one week after receiving MMR II.  At the time of reporting the patient had not yet recovered.  Follow up information was received from the physician concerning a 20 month old male with no prior medical history, drug reactions or allergies.  It was noted that the patient experienced sudden behavior changes at 20 months of age following vaccination with the first dose of MMR II, manufactured with HSA, and administered on 17-AUG-2004.   Also, an episode of sudden bursts of anger/ rage occurred on approximately 31-MAR-2008, 7 days after the patient received a second dose, subcutaneously into the left arm, of MMR II (lot # 659540/1745U).  It was noted that during that episode the patient was running out of control, sweating, and had no eye contact.  When the mother tried to hold the patient down, the patient fought, would bite, cried hysterically and said vicious words.  It was noted that there were similar reports of rage - at least 8 times.  On 2 MAY 2008 the mother reported that the events were 90% less intense, and that she can talk to the patient and that he calms down sooner.  It was noted that prior to the onset of rage (NOS), the patient complained that he could not move his head, and his arms and legs hurt.  Additional information has been requested.
Age: 1.3
Sex: F
Vaccine: MMR
Symptoms: Erythema, Rash generalised
Clinical narrative: Information has been received from a physician concerning a 15 month old female no pertinent medical history, drug reactions or allergies who on 03-APR-2008 was vaccinated subcutaneously with a first dose, 0.5ml of MMR (Lot #657118/0865U). There was no concomitant medication. On 15 APR 2008, the patient developed a red, generalized rash, for which she was seen "in the office" the following day (16 APR 2008). There were no lab diagnostic studies performed. At the time of reporting the patient had not yet recovered. There was no product quality complaint. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody negative, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a registered nurse concerning a now 25 year old male medical student who on 10-Apr-2008 was vaccinated with a third dose of MMRII. The nurse reported the medical student had negative titers for MMR II despite having two doses of MMR II in the past. The medical student was given his first dose 14-Oct-1982 and his second 03-Aug-1995. The nurse indicated she gave him a booster dose on 10-Apr-2008. At the time of the report, the patient's outcome was unknown. Information has been received from a health professional concerning a patient who received MMRII on 06-Jan-1984 and 03-Aug-1995. The patient had to prove immunity by titers. The titers drawn on 25-Mar-2008 were negative for measles, mumps and rubella. A boosters dose of MMR II was given on 10-Apr-2008 Lot 06674; Exp 23-Apr-2010. It was reported that the patient's hepatitis B titer returned also as negative and the question arose regarding the timing of administration of TWINRIX. It was advised to give the TWINRIX at anytime post MMR II. The patient received on 21-Apr-2008 1 dose TWINRIX Lot AHABB100A, EXP 05-Dec-2009. The patient also had an immune work-up that was negative. A post dose measles, mumps and rubella titer was done on 16-May-2008; measles-equivocal, mumps-negative, rubella-positive. Subsequently the patient had a booster dose of  MMR II, R/SQ at 10:00am on 20-Jun-2008, Lot 06674; Exp 23-Apr-2010. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Measles, Rash morbilliform, Stomatitis
Clinical narrative: Information has been received from a physician concerning a 12 month old male with no pertinent medical history, drug reactions or allergies who on 03-APR-2008 was vaccinated with 0.5 ml of MMRII (lot # "04284").  There was no concomitant medication.  On 6 APR 2008 the patient developed a measles like rash throughout his body and some redness in the mouth.  On 16 APR 2008 the patient went to the emergency room (ER) and was released.  On 18 APR 2008 the patient was seen "in the office" for a "typical measles rash".  It was noted that no treatment was required.  At the time of reporting the patient had not yet recovered.  There was no product quality complaint.  Follow-up information has been received from a physician concerning this 12 month old male child who on 03-APR-2008 was vaccinated IM with MMRII (lot # 656915/0428U).  Suspect vaccination included IM VARIVAX (Merck) (lot # 658374/1117U) on the same date.  Subsequently, on 06-APR-2008 the patient developed a morbilliform rash.  The rash started on the patient's face and within 2-3 days the rash had spread to the patient's legs and arms.  Otherwise the patient was well.  It was also reported that the patient recovered on 28-APR-2008.  Additional information is not expected.
Age: 8.0
Sex: M
Vaccine: MMR
Symptoms: Measles antibody positive, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a registered nurse concerning a male with no pertinent medical history and no drug reactions/allergies who on 09-AUG-1996 was vaccinated with the first dose of MMR. The second dose of MMR was administered subcutaneously on 24-AUG-1999. There was no concomitant medication. In early April 2008 (about a month ago), the measles and rubella came back positive and the mumps titer was negative. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 12 month old female who was vaccinated with MMR II. Concomitant therapy included VARIVAX (Merck). It was only known that they received MMR II and VARIVAX (Merck). It was not certain if they were administered concomitantly or in what order. Subsequently, the patient experienced rash and fever of 101 degrees F. This is one of several reports from the same source. Additional information has been requested.
Age: 1.2
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Streptococcal identification test negative, Urticaria
Clinical narrative: Information has been received from a physician concerning a 14 month old female with a history of urinary tract infection and no known drug reactions/allergies who on 16-APR-2008 was vaccinated SC with a 0.5 mL dose of MMR II (lot # 656949/1310U). Secondary suspect therapy included a dose of VARIVAX (lot # 659000/1491U). The patient was seen on 22-APR-2008 in the physician's office for urticaria. A strep test on 22-APR-2008 was negative. No further information is available.
Sex: U
Vaccine: MMR
Symptoms: Rubella antibody negative
Clinical narrative: Information has been received from a health professional concerning an adult patient who was vaccinated with MMR II as a child and had a negative titer in the Fall of 2007. The patient was vaccinated subcutaneously with a 0.5 ml booster dose of MMR II (Wistar RA 27/3 0.5 ml in the fall of 2007. A titer was redrawn in December 2007, and the patient remained negative for rubella. No additional information is available.
Age: 1.3
Sex: F
Vaccine: DTAP, MMR, VARCEL
Symptoms: Irritability, Rash erythematous, Rash maculo-papular
Clinical narrative: Information has been received from a health professional concerning a 15 month old female with a penicillin allergy who on 31-JAN-2008 was vaccinated with a "single dose" of MMR II subcutaneously (SC) (Lot # 654893/1029F). Secondary suspect therapy included VARIVAX. On 11-FEB-2009 the patient developed a red macular/papular rash on her trunk and extremities. The patient was seen in the doctor's office on 12-Feb-2008. The red macular/papular rash lasted for 48 hours and then resolved. Additional information was received from the health professional who reported that the patient received a fourth dose of TRIPEDIA (Lot number U2291BA), intramuscularly, on 31-JAN-2008. It was reported that the patient had a viral illness on 24-JAN-2008 prior to exam. It was reported that the patient was allergic to amoxicillin which caused hives. It was reported that at the time of the rash, the patient was cranky, but she did not have a fever. It was reported that the patient's birth weight was 20 lbs., 2 oz, and that she had one sibling.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Laboratory test abnormal, Mumps, Mumps antibody test positive, Parotid gland enlargement, Swelling
Clinical narrative: Information has been received from a physician concerning a patient who was vaccinated with 2 doses of MMR II. Subsequently, the patient developed mumps symptoms (mumps around the jawline). The patient was seen in the physician's office, who conducted unspecified tests which revealed "positive with mumps." The patient outcome was not provided. Additional information has been received from a physician indicating that the 10 year old female patient was vaccinated with MMR II on 07-OCT-1999 and 02-SEP-2003. On 07-MAR-2008, the patient was diagnosed with parotitic (mumps) and R swelling. Laboratory tests included a mumps titer on 07-MAR-2008 with a value of 0.32 and another mumps titer on 19-MAR-2008 with a value of 1.15. Additional information is not expected.
Sex: F
Vaccine: MMR
Symptoms: Urticaria
Clinical narrative: Information has been received from a registered nurse concerning a female allergic to porcine who "at 5 years of age", in approximately 2001, was vaccinated with MMR II. The patient had urticaria from MMR. No further information was available from the nurse as the vaccine was not given in their office. No further information is available.
Sex: F
Vaccine: MMR
Symptoms: No therapeutic response, Rubella antibody negative
Clinical narrative: Information has been received from a pharmacist concerning a female who in the past was vaccinated with a dose of MMR II. Subsequently the patient was not immune to rubella. The patient was tested from titers which showed that she had not responded to the rubella portion of the vaccine. The patient was in contact with the nurse practitioner for medical attention. No further details. The outcome was unknown. It was noted that the patient brought in a prescription for HPV-77 (MSD) to the reporter. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Measles, Rash morbilliform
Clinical narrative: Information has been received from a physician concerning a 12 month old male who, in February 2008, was vaccinated with MMR II. Concomitant therapy included VARIVAX (MSD), hepatitis A vaccine (inactive) (manufacturer unknown) and PREVNAR. Eleven days post vaccination, in approximately February 2008, the patient experienced measles described as a "systemic measles like rash." The patient was seen by the physician. Subsequently, the patient recovered from measles with systemic measles like rash. This is one of two reports from the same source. Additional information has been requested.
Sex: U
Vaccine: DTAP, MMR
Symptoms: Extrapyramidal disorder, No reaction on previous exposure to drug, Pyrexia
Clinical narrative: Information has been received from a physician concerning a patient who on 01-MAY-2008 was vaccinated with a second dose of MMR II. Concomitant therapy included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unspecified). On 01-MAY-2008 the patient developed an extrapyramidal reaction. The patient had no problem after vaccination with the first dose of MMR II. It was unspecified if medical attention was sought. There was no product quality complaint involved. No further information was provided. Additional information has been received from a physician indicating that the patient did not experience an adverse event, only a febrile response. Additional information has been requested.
Age: 27.0
Sex: M
Vaccine: MMR
Symptoms: Antibody test negative, Mumps antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning an approximately 27 year old male consumer with no known allergies or pertinent medical history who in 1978 was vaccinated with one dose of MMR II. In 2004, medical attention was sought, the patient was seen in the office and a mumps titer was performed. It was reported that the patient had a negative titer for mumps. At the time of the report the patient had not recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Measles, Rash morbilliform
Clinical narrative: Information has been received from a consumer concerning a 12-month-old male who, on an unknown date, was vaccinated subcutaneous with 0.5 ml dose of MMR II. On an unspecified date, post vaccination, the patient developed a measles like rash. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. No further information is available.
Age: 5.0
Sex: F
Vaccine: MMR
Symptoms: Expired drug administered, Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a health professional concerning a 5 year old female on 06-MAY-2008 was vaccinated with MMR II (lot number 653892/0538F) that expired on 29-Apr-2008. No adverse reactions were noted. Unspecified medical attention was sought in an office visit. Additional information has been received from a health professional indicating that the patient received her second dose of MMR II (Exp: 29-Apr-2008) subcutaneously in the right thigh on 05-May-2008 at 14:30. No other adverse symptoms were reported but reaction was local injection site with some redness and swelling. Additional information is not expected.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, PNC
Symptoms: Full blood count, Injection site pain, Parotid gland enlargement
Clinical narrative: Information has been received from a physician concerning a 4 year old female, with no pertinent medical history, drug reactions or allergies who on 25-APR-2008 was vaccinated subcutaneously with 0.5 ml of MMRII (lot #657249/0526U).  Concomitant vaccine therapy included tetanus toxoid (MFR unknown), poliovirus vaccine (MFR unknown) and PREVNAR.  On 04-MAY-2008 the patient developed pain at the site of a swollen parotid gland.  The patient was treated with an anti inflammatory medication and fluids.  There was no product quality complaint.  At the time of reporting the patient was recovering.  Additional information has been requested.
Age: 30.0
Sex: F
Vaccine: MMR
Symptoms: Immunology test, Rubella antibody negative
Clinical narrative: Information has been received from a pharmacist concerning an approximately 30 year old female who was vaccinated with her second dose of MMR II. subsequently the patient had a negative  titer for rubella by ELISA testing. The patient had a missing vaccine record. The patient sought unspecified medical attention. The outcome was unknown. There was no product quality complaint. No further information is available.
Age: 2.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 24 month old female who was vaccinated with MMR. Concomitant therapy included VARIVAX (Merck). It was only known that they received MMR and VARIVAX (Merck). It was not certain if they were administered concomitantly or in what order. Subsequently, the patient experienced rash and fever of 101 degrees F. This is one of several reports from the same source. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Information has been received from a physician concerning a 5 year old female who was vaccinated with MMR II. Suspect therapy included VARIVAX (Merck). It was only known that they received MMR II and VARIVAX (Merck). It was not certain if they were administered concomitantly or in what order. Subsequently, the patient experienced rash and fever of 101 degrees F. This is one of several reports from the same source. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site cellulitis, Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a licensed practical nurse concerning a 5 year old female with no pertinent medical history or drug allergies who, on 25-APR-2008, was vaccinated with a second dose of MMR II (lot# 656430/1305U) in the right thigh. Suspect vaccination administered on that same day included a dose of poliovirus vaccine inactivated (unspecified) in the right thigh. Concomitant vaccinations administered on that same day included a dose of VARIVAX in the left thigh and a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid in the left thigh. In 2008, post vaccination, the child developed cellulitis of the right thigh. The patient came into the physician's office for medical attention and was treated with AUGMENTIN. No labs or diagnostic studies were performed. The nurse stated that "the parent of the child has not called the office since then so the child must be recovered." There was no product quality complaint. Follow up information has been received on 01-Jul-2008 from a health professional who reported that a 5 year old female, who on 25-APR-2008, was vaccinated with MMR II (lot # 656430/1305U) SQ/LT at 10:30 am. On 30-APR-2008 the patient experienced right injection site swollen, size of quarter and right injection site red, size of quarter. At this time, it is unknown if the patient recovered. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Injection site erythema, Pyrexia, Rash
Clinical narrative: Information has been received from a licensed practical nurse (LPN) concerning a patient who on approximately 20-MAR-2008 ("in the last 2 weeks") was vaccinated with a 0.5 ml dose of MMR II (lot number and site not reported. It was reported on an unspecified date, that these three patients were experiencing a fever, rash and injection site erythema after receiving MMR II. The patients were reported as recovered on an unspecified date. There was no product quality complaint. Follow up information was received on 11-APR-2008 from a nurse who reported that she did not know the names of these patients and there was no hospitalization. This is one of several reports from the same source. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, PNC, VARCEL
Symptoms: Measles, Pyrexia, Rash morbilliform
Clinical narrative: Information has been received from a physician concerning a 12 month old female who, in February 2008, was vaccinated with MMR II. Concomitant therapy included VARIVAX, hepatitis A vaccine (inactive) (manufacturer unknown) and PREVNAR. Eleven days post vaccination, in approximately February 2008, the patient experienced measles described as a "system measles like rash." The patient was seen by the physician. The patient also experienced fever but on follow up visit the fever had disappeared. Subsequently, the patient recovered from measles with systemic measles like rash. This is one of two reports from the same source.  Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Hypersensitivity
Clinical narrative: Information has been received from a consumer concerning her male son with allergies to eggs, soy, wheat, mustard, peaches, maple syrup, milk, shellfish, and nuts (expect peanuts) who on an unspecified date was vaccinated with a first dose of MMR II. Subsequently, the patient experienced "some allergic reaction" after receiving the vaccination. Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: MMR
Symptoms: Antinuclear antibody negative, Arthralgia, Electromyogram, Full blood count, Hiccups
Clinical narrative: Information has been received from a health professional concerning a 51 year old female with drug allergies to penicillin, iodine and Acetaminophen who on 11-FEB-2008 was vaccinated subcutaneously into the right upper arm with 0.5 ml, a booster dose of MMR II (lot # 655380/1326F). Concomitant therapy included ZYRTEC. On 23-APR-2008 the patient developed severe, intermittent, widespread muscle spasms. The muscle spasms affected primarily the left shoulder, low back and both legs. On 01 MAY 2008 the patient began to have persistent hiccups and widespread joint pain, in addition to the muscle spasms. The patient was referred to a neurologist who ordered a complete blood count, comprehensive metabolic panel, lipase, antinuclear antibody and started the patient on therapy with baciofen. The antibody test was negative, but other test results were pending at the time of reporting. The nurse noted that on 12 MAY 2008 the patient contacted the office with complaints of muscle weakness. A neurologist was consulted who recommended increasing the dose of baclofen. An MRI of the brain and electromyogram were ordered, the results of which were pending at the time of reporting. At the time of reporting the patient had not yet recovered. There was no product quality complaint. Additional information has been requested.
Age: 51.0
Sex: F
Vaccine: MMR
Symptoms: Lipase, Metabolic function test, Muscle spasms, Muscular weakness, Nuclear magnetic resonance imaging
Clinical narrative: Information has been received from a health professional concerning a 51 year old female with drug allergies to penicillin, iodine and Acetaminophen who on 11-FEB-2008 was vaccinated subcutaneously into the right upper arm with 0.5 ml, a booster dose of MMR II (lot # 655380/1326F). Concomitant therapy included ZYRTEC. On 23-APR-2008 the patient developed severe, intermittent, widespread muscle spasms. The muscle spasms affected primarily the left shoulder, low back and both legs. On 01 MAY 2008 the patient began to have persistent hiccups and widespread joint pain, in addition to the muscle spasms. The patient was referred to a neurologist who ordered a complete blood count, comprehensive metabolic panel, lipase, antinuclear antibody and started the patient on therapy with baciofen. The antibody test was negative, but other test results were pending at the time of reporting. The nurse noted that on 12 MAY 2008 the patient contacted the office with complaints of muscle weakness. A neurologist was consulted who recommended increasing the dose of baclofen. An MRI of the brain and electromyogram were ordered, the results of which were pending at the time of reporting. At the time of reporting the patient had not yet recovered. There was no product quality complaint. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Rash erythematous, Rash macular
Clinical narrative: Information has been received from a NP concerning a male with no known medical history or allergies who on 07-MAY-2008 was vaccinated sc with a 0.5 ml dose of MMR II. Concomitant therapy included multivitamins. It was reported on 20-MAY-2008 the patient experienced a red blotchy rash that extended from the upper middle back to the waistline. Patient was seen by the NP. No laboratory test were performed. The patient's outcome was not reported. Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: MMR
Symptoms: Blood amylase increased, Blood immunoglobulin G normal, Inflammation, Mumps antibody test positive, Parotitis
Clinical narrative: Information has been received from a physician concerning a 9 year old male patient who in 2003 was vaccinated with a second dose of MMR II (Merck), initially reported as mumps virus vaccine live (Merck).  On approximately 22-MAY-2008 the patient developed parotitis on one side which was inflamed.  Unspecified medical attention was sought.  Laboratory testing showed serum IgG antibodies elevated at 1.9, IgG negative at < 0.8; and amylase elevated at 3, 450.  It was also reported that there was no known exposure to patients with mumps.  At the time of the report the patient's status was unknown.  Additional information has been requested.
Age: 1.1
Sex: F
Vaccine: MMR
Symptoms: Parotitis
Clinical narrative: Information has been received from a nurse practitioner concerning a 13 month old female with no pertinent medical history or drug allergies who on 28-APR-2008 was vaccinated SC with a 0.5 ml dose of MMRII vaccine. There was no concomitant medication. Recently in May 2008, the child developed a parotitis on her left side. The patient sought unspecified medical attention. No labs or diagnostic studies were performed. The patient was recovering at the time of this report. There was no product quality complaint. No other information was available. Additional information has been requested.
Sex: U
Vaccine: MMR, MU
Symptoms: Measles antibody positive, Mumps antibody test negative, Rubella antibody positive
Clinical narrative: Information has been received from a pharmacist concerning a patient (age, gender unspecified) who thought the patient was vaccinated with a dose of MMR II or dose of MUMPSVAX II (pharmacist not certain what was administered or when) when the patient was a child (date and dose not reported). It was reported that the patient negative mumps titer (dates unspecified). The patient had had acceptable titers of measles and rubella. It is unknown if the patient sought medical attention. No other information reported. A product quality complaint was not involved. No additional information is expected.
Age: 4.0
Sex: M
Vaccine: MMR
Symptoms: Epididymitis, Ultrasound scan abnormal
Clinical narrative: Information has been received from a physician concerning a 4 year old male child who on 25-FEB-2008 was vaccinated with a second dose of MMR II (Merck).  The date of the first vaccination was not provided.  On 12-APR-2008 the patient was seen in the emergency room and an ultrasound showed epididymitis.  The patient was treated with an "unnamed antibiotic."  At the time of the report the patient's status was unknown.  There was no product quality complaint involved.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR
Symptoms: Underdose, Urticaria
Clinical narrative: Information has been received from a physician concerning an "approximately 12 or 13 month old" male child with egg allergy, "very allergic and atopic" who "approximately a month or two ago" was vaccinated SQ with a quarter dose (0.125ml) of a first dose of MMR II (Merck). Subsequently the patient broke out in hives. Unspecified medical attention was sought. It was unspecified if lab studies were performed. The patient was treated with BENADRYL and recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested.
Age: 9.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Information has been received from a health professional concerning a 9 year old male who sometime in 2000 was vaccinated with his first dose of MMR II. The second dose of MMR II was administered to the patient when he was 4 years old. On 09-Jun-2008 the patient inadvertently received a third dose of MMR II (lot number unspecified) instead of VARIVAX (MSD) because of human error. On 09-JUN-2008 the VARIVAX (MSD) (lot number unspecified) was administered as scheduled. No adverse symptoms were noted. Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Follow-up information indicated no new information. Additional information is not expected.
Age: 2.02
Sex: F
Vaccine: MMR
Symptoms: Mumps antibody test negative
Clinical narrative: Information has been received from a physician concerning a 26 month old female patient who was vaccinated with a dose of MMR II vaccine and the patient had a mumps antibody titer that was negative for mumps. The patient's mother asked if mumps virus vaccine live (unspecified) was available through the physician's office since the patient had a titter negative for mumps. There was no additional information because the vaccines were administered elsewhere and the child was not a patient at the physician's office. No product quality complaint was involved. No further information is available.